Leukotac® (anti-IL-2) as salvage treatment of steroid-refractory acute graft-versus-host disease

被引：0
|
作者：
Piñana, JL [1 ]
Valcárcel, D [1 ]
Martino, R [1 ]
Moreno, ME [1 ]
García, P [1 ]
Alvarez, I [1 ]
Sureda, A [1 ]
Briones, J [1 ]
Brunet, S [1 ]
Sierra, J [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [1] Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
    Cazeau, Naomi
    Rodriguez, Stephany L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 397 - 403
  • [2] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    Hoda, D.
    Pidala, J.
    Salgado-Vila, N.
    Kim, J.
    Perkins, J.
    Bookout, R.
    Field, T.
    Perez, L.
    Ayala, E.
    Ochoa-Bayona, J. L.
    Raychaudhuri, J.
    Alsina, M.
    Greene, J.
    Janssen, W.
    Fernandez, H. F.
    Anasetti, C.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1347 - 1351
  • [3] Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillenmo J.
    Tarin-Arzaga, Luz del Carmen
    Gonzalez-Llano, Oscar
    Gutierrez-Aguirre, Homero
    Cantu-Rodriguez, Olga
    Jaime-Perez, Jose
    Carrasco-Yalan, Antonio
    Giralt, Sergio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 10 - 15
  • [4] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    D Hoda
    J Pidala
    N Salgado-Vila
    J Kim
    J Perkins
    R Bookout
    T Field
    L Perez
    E Ayala
    J L Ochoa-Bayona
    J Raychaudhuri
    M Alsina
    J Greene
    W Janssen
    H F Fernandez
    C Anasetti
    M A Kharfan-Dabaja
    Bone Marrow Transplantation, 2010, 45 : 1347 - 1351
  • [5] Salvage therapy with pentostatin for steroid-refractory graft-versus-host disease
    Leopardi, G
    Visani, G
    Giardini, C
    Sparaventi, G
    d'Adamo, F
    Nicolini, G
    Guiducci, B
    Barulli, S
    Malerba, L
    Lucesole, M
    Isidori, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S97 - S97
  • [6] Inolimomab (anti-IL-2-Re) as salvage treatment of steroid-refractory acute graft-versus-host disease:: single-centre experience
    Pinana, J. L.
    Valcarcel, D.
    Martino, R.
    Moreno, E.
    Sureda, A.
    Delgado, J.
    Briones, J.
    Brunet, S.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S226 - S227
  • [7] Ruxolitinib for steroid-refractory acute graft-versus-host disease
    Toama, Wael
    Fiala, Mark
    Pusic, Iskra
    Westervelt, Peter
    Dipersio, John F.
    Schroeder, Mark
    TRANSPLANT INTERNATIONAL, 2020, 33 (02) : 244 - 246
  • [8] Pentostatin in steroid-refractory acute graft-versus-host disease
    Bolaños-Meade, J
    Jacobsohn, DA
    Margolis, J
    Ogden, A
    Wientjes, MG
    Byrd, JC
    Lucas, DM
    Anders, V
    Phelps, M
    Grever, MR
    Vogelsang, GB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2661 - 2668
  • [9] Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease
    Pinana, Jose Luis
    Valcarcel, David
    Martino, Rodrigo
    Moreno, M. Estela
    Sureda, Anna
    Briones, Javier
    Brunet, Salut
    Sierra, Jorge
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (11) : 1135 - 1141
  • [10] Strategy on the Treatment of Steroid-Refractory Severe acute Graft-versus-Host Disease
    Yamin, T.
    Yi, L.
    Kaili, D.
    He, H.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S393 - S394
12345